Infection of red blood cells by SARS-CoV-2: new evidence.
作者信息
Khawaja Uzzam Ahmed, Shamsoddin Erfan, Desideri Lorenzo Ferro, Tovani-Palone Marcos Roberto
机构信息
Department of Medicine, Jinnah Medical and Dental College, Karachi, Pakistan.
National Institute for Medical Research Development, Tehran, Iran.
出版信息
Einstein (Sao Paulo). 2021 Apr 16;19:eCE6285. doi: 10.31744/einstein_journal/2021CE6285. eCollection 2021.
Abstract
摘要
相似文献
1
Infection of red blood cells by SARS-CoV-2: new evidence.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对红细胞的感染：新证据
Einstein (Sao Paulo). 2021 Apr 16;19:eCE6285. doi: 10.31744/einstein_journal/2021CE6285. eCollection 2021.
2
Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.母亲在确诊 COVID-19 PCR、出现病毒症状且未暴露于病毒的情况下，母乳中针对 SARS-CoV-2、HCoV-OC43 和 HCoV-229E 的 S1 和 S2 亚单位的人乳抗体。
Int J Mol Sci. 2021 Feb 9;22(4):1749. doi: 10.3390/ijms22041749.
3
Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.SARS-CoV-2 在 COVID-19 患者中的长期存在：宿主免疫、病毒毒力和传染性。
Virol Sin. 2020 Dec;35(6):793-802. doi: 10.1007/s12250-020-00308-0. Epub 2020 Nov 6.
4
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.通过快速诊断免疫分析检测 COVID-19 患者的 SARS-CoV-2 特异性抗体。
Virol J. 2021 Mar 9;18(1):52. doi: 10.1186/s12985-021-01530-2.
5
SARS-CoV-2 in first trimester pregnancy: a cohort study.SARS-CoV-2 在孕早期：一项队列研究。
Hum Reprod. 2021 Jan 1;36(1):40-47. doi: 10.1093/humrep/deaa311.
6
Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.可能存在 COVID-19 母亲所生婴儿的垂直传播和针对 SARS-CoV-2 的抗体：一项实时系统评价。
J Med Virol. 2021 Mar;93(3):1361-1369. doi: 10.1002/jmv.26622. Epub 2020 Nov 10.
7
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020.2020 年 4 月至 6 月，泰国新冠肺炎康复病例的 SARS-CoV-2 病毒 RNA 脱落情况，以及新冠肺炎康复病例和密切接触者中针对 SARS-CoV-2 的抗体情况。
PLoS One. 2020 Oct 29;15(10):e0236905. doi: 10.1371/journal.pone.0236905. eCollection 2020.
8
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.针对 SARS-CoV-2 和其他人类冠状病毒的中和抗体。
Trends Immunol. 2020 May;41(5):355-359. doi: 10.1016/j.it.2020.03.007. Epub 2020 Apr 2.
9
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
10
SARS-CoV-2 infection and neonates: a review of evidence and unresolved questions.严重急性呼吸综合征冠状病毒 2 感染与新生儿：证据回顾与未决问题。
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26(Suppl 26):79-81. doi: 10.1111/pai.13349.
引用本文的文献
1
Roles of Erythrocytes in Human Health and Disease 2.0.红细胞在人类健康与疾病中的作用2.0
Int J Mol Sci. 2024 Apr 18;25(8):4446. doi: 10.3390/ijms25084446.
2
Changes in Hematological and Hemorheological Parameters Following Mild COVID-19: A 4-Month Follow-Up Study.轻度新型冠状病毒肺炎后血液学和血液流变学参数的变化：一项4个月的随访研究
Hematol Rep. 2023 Oct 10;15(4):543-554. doi: 10.3390/hematolrep15040057.
3
Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission.血清高迁移率族蛋白 1 和血红素加氧酶-1 作为 COVID-19 患者入院时的生物标志物。
Int J Mol Sci. 2023 Aug 24;24(17):13164. doi: 10.3390/ijms241713164.
4
Coagulation Disorders in Sepsis and COVID-19-Two Sides of the Same Coin? A Review of Inflammation-Coagulation Crosstalk in Bacterial Sepsis and COVID-19.脓毒症和新冠肺炎中的凝血障碍——同一枚硬币的两面？细菌感染性脓毒症和新冠肺炎中炎症与凝血相互作用的综述
J Clin Med. 2023 Jan 11;12(2):601. doi: 10.3390/jcm12020601.
5
Is hemolysis a novel therapeutic target in COVID-19?溶血是新冠病毒肺炎的一个新的治疗靶点吗？
Front Immunol. 2022 Aug 19;13:956671. doi: 10.3389/fimmu.2022.956671. eCollection 2022.
6
Detection of erythroid progenitors and erythrocytopathies in patients with severe COVID-19 disease.检测严重 COVID-19 患者中的红系祖细胞和红细胞病变。
Saudi Med J. 2022 Aug;43(8):899-906. doi: 10.15537/smj.2022.43.8.20220311.
7
COVID-19 and erythrocrine function: The roller coaster and danger.COVID-19 与红细胞功能：过山车与危险。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221103151. doi: 10.1177/03946320221103151.
8
Modified Hemagglutination Tests for COVID-19 Serology in Resource-Poor Settings: Ready for Prime-Time?资源匮乏地区用于新冠病毒血清学检测的改良血凝试验：准备好进入黄金时段了吗？
Vaccines (Basel). 2022 Mar 8;10(3):406. doi: 10.3390/vaccines10030406.
9
Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects.新型冠状病毒肺炎对红细胞功能的影响：红细胞的生化影响和形态功能方面。
Int J Mol Sci. 2022 Feb 16;23(4):2171. doi: 10.3390/ijms23042171.
10
Is haem the real target of COVID-19?血液是 COVID-19 的真正靶点吗？
Photodiagnosis Photodyn Ther. 2021 Sep;35:102381. doi: 10.1016/j.pdpdt.2021.102381. Epub 2021 Jun 11.
本文引用的文献
1
Evidence of Structural Protein Damage and Membrane Lipid Remodeling in Red Blood Cells from COVID-19 Patients.新型冠状病毒肺炎患者红细胞结构蛋白损伤和膜脂重塑的证据。
J Proteome Res. 2020 Nov 6;19(11):4455-4469. doi: 10.1021/acs.jproteome.0c00606. Epub 2020 Oct 26.
2
Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection.红细胞分布宽度与住院成人 SARS-CoV-2 感染患者死亡风险的关联。
JAMA Netw Open. 2020 Sep 1;3(9):e2022058. doi: 10.1001/jamanetworkopen.2020.22058.
3
Epidemiologic and clinical features of patients with COVID-19 in Brazil.巴西新冠肺炎患者的流行病学和临床特征。
Einstein (Sao Paulo). 2020;18:eAO6022. doi: 10.31744/einstein_journal/2020ao6022. Epub 2020 Aug 14.
4
Epidemiology and clinical features of COVID-19: A review of current literature.新型冠状病毒肺炎的流行病学和临床特征：文献复习。
J Clin Virol. 2020 Jun;127:104357. doi: 10.1016/j.jcv.2020.104357. Epub 2020 Apr 10.
Zotero 插件